TR200001046T2 - Homolog rekombinasyonda pozitif-negatif seçimi. - Google Patents

Homolog rekombinasyonda pozitif-negatif seçimi.

Info

Publication number
TR200001046T2
TR200001046T2 TR2000/01046T TR200001046T TR200001046T2 TR 200001046 T2 TR200001046 T2 TR 200001046T2 TR 2000/01046 T TR2000/01046 T TR 2000/01046T TR 200001046 T TR200001046 T TR 200001046T TR 200001046 T2 TR200001046 T2 TR 200001046T2
Authority
TR
Turkey
Prior art keywords
homologous recombination
positive
negative selection
introducing
target cell
Prior art date
Application number
TR2000/01046T
Other languages
English (en)
Inventor
Auer Johannes
Sprenger Raimund
Honold Konrad
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200001046(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR200001046T2 publication Critical patent/TR200001046T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Bulus, homolog rekombinasyonla bir hedef hücre genomuna yabanci bir DNA'nin sokulmasi için ve uygun DNA yapilarinin homolog rekombinasyonu için bir yönteme iliskindir.
TR2000/01046T 1997-10-20 1998-10-20 Homolog rekombinasyonda pozitif-negatif seçimi. TR200001046T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97118175 1997-10-20

Publications (1)

Publication Number Publication Date
TR200001046T2 true TR200001046T2 (tr) 2001-07-23

Family

ID=8227499

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01046T TR200001046T2 (tr) 1997-10-20 1998-10-20 Homolog rekombinasyonda pozitif-negatif seçimi.

Country Status (17)

Country Link
US (1) US6284541B1 (tr)
EP (1) EP1025253B2 (tr)
JP (1) JP4417549B2 (tr)
KR (1) KR100566702B1 (tr)
CN (1) CN1146666C (tr)
AR (1) AR017368A1 (tr)
AT (1) ATE260982T1 (tr)
AU (1) AU730466B2 (tr)
BR (1) BR9813099B1 (tr)
CA (1) CA2306229C (tr)
DE (1) DE59810925D1 (tr)
DK (1) DK1025253T4 (tr)
ES (1) ES2213925T5 (tr)
PT (1) PT1025253E (tr)
TR (1) TR200001046T2 (tr)
WO (1) WO1999020780A1 (tr)
ZA (1) ZA989497B (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220221B2 (en) * 2000-05-03 2007-05-22 Nautilus, Inc. Exercise device with body extension mechanism
US6929909B2 (en) 2000-09-15 2005-08-16 Deltagen, Inc. Gene targeting vectors comprising conditional positive selection markers
WO2002055687A2 (en) * 2000-12-13 2002-07-18 Deltagen Inc Transgenic mice containing target gene disruptions
WO2003027261A2 (en) * 2001-09-27 2003-04-03 Functional Genetics, Inc. Methods and compositions for gene targeting by homologous recombination
DE50115580D1 (de) † 2001-10-01 2010-09-16 Deutsches Krebsforsch Verfahren zur Herstellung von Protein-Bibliotheken und zur Selektion von Proteinen daraus
US20030135872A1 (en) * 2001-12-04 2003-07-17 Burgess Robert M. Gene targeting methods and vectors
AU2003231244A1 (en) * 2002-05-02 2003-11-17 University Of North Carolina At Chapel Hill In vitro mutagenesis, phenotyping, and gene mapping
FR2860517B1 (fr) * 2003-10-03 2006-02-10 Evologic Sa Procedes et outils pour la modification chromosomique de bacteries
EP1859037A2 (en) 2005-03-08 2007-11-28 BASF Plant Science GmbH Expression enhancing intron sequences
JP5087625B2 (ja) 2006-09-01 2012-12-05 セラピューティック・ヒューマン・ポリクローナルズ・インコーポレーテッド 非ヒトトランスジェニック動物におけるヒトまたはヒト化免疫グロブリンの発現強化
UA100692C2 (ru) 2007-05-02 2013-01-25 Мериал Лимитед Днк-плазмиды, имеющие повышенную экспрессию и стабильность
WO2009130598A1 (en) * 2008-04-21 2009-10-29 Unitargeting Research As Genetically modified eukaryotic cells
CN102618453A (zh) * 2011-10-31 2012-08-01 四川农业大学 猪传染性胸膜肺炎放线杆菌Apx I C基因缺失突变株、构建方法、疫苗及应用
JP6037290B2 (ja) 2011-12-13 2016-12-07 公立大学法人横浜市立大学 遺伝子ターゲティングベクター及びその利用方法
DE102014116334A1 (de) * 2014-11-10 2016-05-12 Eberhard Karls Universität Tübingen Medizinische Fakultät Herstellung von rekombinanten Expressionsvektoren

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01203975A (ja) * 1988-02-09 1989-08-16 Konica Corp 流体試料中の特定成分の測定方法
DE3907679A1 (de) * 1989-03-09 1990-09-13 Max Planck Gesellschaft Verfahren zur gezielten veraenderung eines gens
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
EP0747485B1 (en) † 1989-11-06 1998-12-02 Cell Genesys, Inc. Production of proteins using homologous recombination
CA2040099A1 (en) 1990-05-01 1991-11-02 Mariano Barbacid Tyrosine kinase negative trkb
EP0559834A1 (en) * 1990-11-30 1993-09-15 Abbott Laboratories Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
PT101031B (pt) † 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
ES2240962T3 (es) * 1993-06-04 2005-10-16 The United States Of America As Represented By The Secretary Of The Navy Metodo para estimular selectivamente la proliferacion de celulas t.
IT1261847B (it) 1993-09-01 1996-06-03 San Romanello Centro Fond Metodo per marcare cellule eucariote.
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6017754A (en) * 1995-08-24 2000-01-25 Invitrogen Corporation System for isolating and identifying eukaryotic cells transfected with genes and vectors, host cells and methods thereof

Also Published As

Publication number Publication date
CN1146666C (zh) 2004-04-21
BR9813099A (pt) 2000-08-22
DE59810925D1 (de) 2004-04-08
JP2001523442A (ja) 2001-11-27
CA2306229C (en) 2011-03-22
EP1025253B2 (de) 2009-07-29
BR9813099B1 (pt) 2010-02-09
CA2306229A1 (en) 1999-04-29
CN1276836A (zh) 2000-12-13
AU730466B2 (en) 2001-03-08
EP1025253B1 (de) 2004-03-03
DK1025253T3 (da) 2004-07-12
DK1025253T4 (da) 2009-08-31
ZA989497B (en) 2000-04-19
US6284541B1 (en) 2001-09-04
WO1999020780A1 (de) 1999-04-29
PT1025253E (pt) 2004-07-30
AR017368A1 (es) 2001-09-05
ES2213925T5 (es) 2009-11-11
ES2213925T3 (es) 2004-09-01
ATE260982T1 (de) 2004-03-15
JP4417549B2 (ja) 2010-02-17
KR20010031277A (ko) 2001-04-16
KR100566702B1 (ko) 2006-04-03
AU1229399A (en) 1999-05-10
EP1025253A1 (en) 2000-08-09

Similar Documents

Publication Publication Date Title
TR200001046T2 (tr) Homolog rekombinasyonda pozitif-negatif seçimi.
DE69906977D1 (de) In liposomen verkapselte nukleinsäurekomplexe
DK1137798T3 (da) Fremgangsmåde til isolering af stamceller
DE69636288D1 (de) Samenstrenung resistenz
PL322611A1 (en) Methods of obtaining l-amini acid by fermentation, dna as well as micro-organism
AU4981101A (en) Subtilisin variants
DE69637631D1 (de) Künstliche säuger chromosome
HK1158529A1 (en) Promoters exhibiting endothelial cell specificity and methods of using same
DK0972445T3 (da) Kimærisk mus som udtrykker et humant antistof
ATE526818T1 (de) Gentechnisch hergestellte wasserlinse
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
CY1115543T1 (el) Dνα ανασυνδυασμος ειδικης ακολουθιας σε ευκαρυωτικα κυτταρα
MX9805507A (es) Composicion para la transfeccion de celulas eucarioticas superiores.
NO20000097L (no) Isolerte dendrittcellemembranproteingener
TR200403501T2 (tr) Transgenik bitki ve metotları.
DK0731845T3 (da) Homologt rekombinant antistofekspressionssystem til murine celler
TR200000858T2 (tr) Meyve oluşumu ve gelişimini güçlendirme yöntemleri
GB0020331D0 (en) Enzyme
DZ2292A1 (fr) Méthode concernant l'immortalité des cellules.
WO2003089617A3 (en) Methods for increasing homologous recombination of a nucleic acid sequence
WO2001073001A3 (en) Establishment of cellular manipulations which enhance oligo-mediated gene targeting
ZA986517B (en) Production of human mutated proteins in human cells by means of homologous recombination.
GB9910796D0 (en) Dna
WO1999063071A3 (de) Verfahren zur auslösung von apoptose in zellen
TW401985U (en) High efficiency aeration, fungus culture biochemical brick